Literature DB >> 32275257

Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period.

Mahdi Asghari Ozma1, Parham Maroufi2, Ehsaneh Khodadadi3, Şükran Köse4, Isabella Esposito5, Khudaverdi Ganbarov6, Sounkalo Dao7, Silvano Esposito5, Tuba Dal8, Elham Zeinalzadeh9, Hossein Samadi Kafil10.   

Abstract

The novel coronavirus SARS-CoV-2 (Covid-19), spreading from Wuhan, China, is one of the causes of respiratory infections that can spread to other people through respiratory particles, and can cause symptoms such as fever, dry cough, shortness of breath, anorexia, fatigue and sore throat in infected patients. This review summarizes current strategies on the diagnosis. Additionally, treatments, infection prevention and control of the SARS-CoV-2 are addressed. In addition to the respiratory system, this virus can infect the digestive system, the urinary system and the haematological system, which causes to observe the virus in the stool, urine and blood samples in addition to throat sample. The SARS-CoV-2 causes changes in blood cells and factors and makes lung abnormalities in patients, which can be detected by serological, molecular, and radiological techniques by detecting these changes and injuries. Radiological and serological methods are the most preferred among the other methods and the radiological method is the most preferred one which can diagnose the infection quickly and accurately with fewer false-negatives, that can be effective in protecting the patient's life by initiating treatment and preventing the transmission of infection to other people.

Entities:  

Mesh:

Year:  2020        PMID: 32275257

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  37 in total

Review 1.  COVID-19 in Africa: an ovarian victory?

Authors:  Osman A Dufailu; Afrakoma Afriyie-Asante; Bernard Gyan; David Adu Kwabena; Helena Yeboah; Frank Ntiakoh; Meshach Asare-Werehene
Journal:  J Ovarian Res       Date:  2021-05-21       Impact factor: 4.234

2.  TaibUVID nutritional supplements help rapid cure of COVID-19 infection and rapid reversion to negative nasopharyngeal swab PCR: for better public prophylaxis and treatment of COVID-19 pandemic.

Authors:  Salah Mohamed El Sayed; Moutasem Salih Aboonq; Yasmeen Talal Aljehani; Mohammad Ahmad Hassan; Rabab M Abou El-Magd; Abdelrahman I Abdelrahman; Rehab El-Tahlawi; Manal Mohamed Helmy Nabo; Reda S Yousef; Ahmed Alamir Mahmoud; Yasser Yahia Elsayed; Mostafa Abu-Elnaga; Tamer M Soliman; Abdelhady Ragab Abdel-Gawad; Momen Elshazley; Hussam Baghdadi; Samer El-Sawy; Hany Salah Mahmoud; Mariam E El-Anzi; Mansour Barakah Alharbi
Journal:  Am J Blood Res       Date:  2020-12-15

Review 3.  Can food matrices be considered as a potential carrier for COVID-19?

Authors:  Amin Abbasi; Hossein Samadi Kafil; Mahdi Asghari Ozma; Narges Sangtarash; Sahar Sabahi
Journal:  Infez Med       Date:  2022-03-01

Review 4.  Acute hepatitis (Non Hepa A-E) of unknown origin among pediatrics.

Authors:  Nasim Asadi Faezi; Bahareh Mehramouz; Sepehr Taghizadeh; Pasquale Pagliano; Hossein Samadi Kafil
Journal:  Infez Med       Date:  2022-09-01

5.  Alteration of Liver Biomarkers in Patients with SARS-CoV-2 (COVID-19).

Authors:  Pourya Gholizadeh; Rohollah Safari; Parham Marofi; Elham Zeinalzadeh; Pasquale Pagliano; Khudaverdi Ganbarov; Silvano Esposito; Ehsaneh Khodadadi; Mehdi Yousefi; Hossein Samadi Kafil
Journal:  J Inflamm Res       Date:  2020-07-01

6.  The Main Sources and Potential Effects of COVID-19-Related Discrimination.

Authors:  Piotr Rzymski; Hanna Mamzer; Michał Nowicki
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  The next-generation coronavirus diagnostic techniques with particular emphasis on the SARS-CoV-2.

Authors:  Maged G Hemida
Journal:  J Med Virol       Date:  2021-03-26       Impact factor: 2.327

8.  Bacteremia during COVID-19 pandemic in a tertiary hospital in Spain.

Authors:  Saray Mormeneo Bayo; María Pilar Palacián Ruíz; Miguel Moreno Hijazo; María Cruz Villuendas Usón
Journal:  Enferm Infecc Microbiol Clin (Engl Ed)       Date:  2022-04

9.  Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation.

Authors:  Ting Xiao; Mengqi Cui; Caijuan Zheng; Ming Wang; Ronghao Sun; Dandi Gao; Jiali Bao; Shanfa Ren; Bo Yang; Jianping Lin; Xiaoping Li; Dongmei Li; Cheng Yang; Honggang Zhou
Journal:  Front Pharmacol       Date:  2021-06-17       Impact factor: 5.810

Review 10.  CAR T-cell treatment during the COVID-19 pandemic: Management strategies and challenges.

Authors:  Yongxian Hu; Elaine Tan Su Yin; Yingying Yang; Hengwei Wu; Guoqing Wei; Junwei Su; Qu Cui; Aiyun Jin; Li Yang; Shan Fu; Jianfeng Zhou; Lugui Qiu; Xi Zhang; Aibin Liang; Hongmei Jing; Yuhua Li; Didier Blaise; Mohamad Mohty; Arnon Nagler; He Huang
Journal:  Curr Res Transl Med       Date:  2020-06-28       Impact factor: 4.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.